4D Molecular Therapeutics Inc (FDMT) — Free Cash Flow Generation Index
4D Molecular Therapeutics Inc (FDMT) has a Free Cash Flow Generation Index of 0.98x as of December 2025. Free cash flow of $27.92 Million represents 1% of operating cash flow ($28.55 Million). Explore FDMT capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
4D Molecular Therapeutics Inc Free Cash Flow Generation Index (2017–2017)
Historical FCF Generation Index trend for 4D Molecular Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does 4D Molecular Therapeutics Inc generate cash.
Annual Free Cash Flow Generation for 4D Molecular Therapeutics Inc (2017–2017)
Year-by-year Free Cash Flow Generation Index for 4D Molecular Therapeutics Inc. Check 4D Molecular Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2017 | 0.93x | $7.66 Million | $8.24 Million | $573.00K | — |